Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by do Pico, G.
Right arrow Articles by Dickie, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by do Pico, G.
Right arrow Articles by Dickie, H.

Chest, Vol 75, 688-692, Copyright © 1979 by American College of Chest Physicians

ARTICLES

Pulmonary reaction to upper mantle radiation therapy for Hodgkin's disease

GA do Pico, AL Wiley Jr, P Rao and HA Dickie

To study the effects of upper mantle radiation therapy on pulmonary function, forced expiratory volume in one second (FEV1), vital capacity (VC), inspiratory capacity (IC), diffusing capacity for CO (DLCO) and diffusion per unit of alveolar volume (DL/VA were determined in 28 patients with Hodgkin's disease, stages 1--3, before therapy and at regular intervals thereafter. Within the first year of follow-up there were significant declines in DLCO, VC, and IC, whereas there were no significant changes in FEV1 or DL/VA. DLCO showed the greatest decline in the largest number of subjects (22/28). Eleven of the 22 had 20 to 60 percent decline of DLCO from baseline. The maximum mean decline in DLCO was -12.7 +/- 3 percent at the 87th +/- 3 days from initiation of therapy postradiation sustained through the 150th day and improving to pretreatment value (+/- 5 percent) by the 8th to 12th month. The changes in DLCO seemed to be independent of the radiation dose ranges evaluated, clinically apparent intrathoracic lymphoma, postradiation radiographic abnormalities and respiratory symptoms. We concluded that impairment in diffusing capacity and loss of vital capacity will develop in most patients receiving upper mantle radiation therapy, indicating that pulmonary reaction occurs despite lung shielding. The functional losses were prolonged and occasionally severe, but were transient and subclinical in most but not all cases. A case of fatal radiation pneumonitis affecting the lung beyond the field of irradiation is reported.


This article has been cited by other articles:


Home page
 ChestHome page
R. B. Bonnet, D. Bush, G. A. Cheek, J. D. Slater, D. Panossian, C. Franke, and J. M. Slater
Effects of Proton and Combined Proton/Photon Beam Radiation on Pulmonary Function in Patients With Resectable but Medically Inoperable Non-small Cell Lung Cancer
Chest, December 1, 2001; 120(6): 1803 - 1810.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. Rolla, U. Ricardi, P. Colagrande, D. Nassisi, L. Dutto, G. Chiavassa, and C. Bucca
Changes in Airway Responsiveness Following Mantle Radiotherapy for Hodgkin's Disease
Chest, June 1, 2000; 117(6): 1590 - 1596.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. C.M. Theuws, S. H. Muller, Y. Seppenwoolde, S. L.S. Kwa, L. J. Boersma, G. A.M. Hart, P. Baas, and J. V. Lebesque
Effect of Radiotherapy and Chemotherapy on Pulmonary Function After Treatment for Breast Cancer and Lymphoma: A Follow-Up Study
J. Clin. Oncol., October 1, 1999; 17(10): 3091 - 3100.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1979 by the American College of Chest Physicians.